Skip to main content
. Author manuscript; available in PMC: 2021 Aug 14.
Published in final edited form as: Mol Cancer Ther. 2020 Sep 2;19(11):2267–2277. doi: 10.1158/1535-7163.MCT-19-0822

Fig. 3. A novel HuR inhibitor KH-3 disrupts HuR-mRNA interaction, and inhibits pancreatic cancer cell viability.

Fig. 3

A. Chemical structure of KH-3. B. Inhibition of cell viability by KH-3. C. Upper: Western blot showing endogenous HuR levels of the tested cell lines. Lower: The correlation between HuR levels and the sensitivity of cells to KH-3 treatment. Bars show relative band density of HuR normalized to GAPDH, and the line shows IC50 values of KH-3.